54. Discovery of Picomolar ABL Kinase Inhibitors Equipotent for Wild Type and T315I Mutant via Structure-Based de novo Design

Park, H.; Hong, S.; Kim, J.; Hong, S.

J. Am. Chem. Soc. 2013, 135, 8227.  

53. Synthesis of Heterocyclic-Fused Benzofurans via C–H Functionalization of Flavones and Coumarins

Moon, Y.; Kim, Y.; Hong, H. Hong, S.

Chem. Commun. 2013, 49, 8323. 

52. HS-173, a novel phosphatidylinositol 3-kinase (PI3K) inhibitor, has anti-tumor activity through promoting apoptosis and inhibiting angiogenesis

Lee, S.; Jung, K. H.; Jeong, Y.; Hong, S.*; Hong, S.-S.*

Cancer Lett. 2013, 328, 152-159.

51. HS-173, a Novel PI3K Inhibitor, Attenuates the Activation of Hepatic Stellate Cells in Liver Fibrosis

Son, M. K.; Ryu, Y. L.; Jung, K. H.; Lee, H. S.; Lee, H. S.; Yan, H. H.; Park, H. J.; Ryu, K. k.; Suh, J. k.; Hong, S.; Hong, S.-S.*

Sci. Rep. 2013, 3, 3470.

50. Suppression of Tumor Proliferation and Angiogenesis of Hepatocellular Carcinoma by HS-104, a Novel Phosphoinositide 3-Kinase Inhibitor

Jung, K. H.; Zheng, H.-M; Jeong, Y.; Choi, M.-J.; Lee, H.; Hong, S.W.; Lee, H.-S.; Lee, S.; Hong, S.*; Hong, S.-S.*

Cancer Lett. 2013, 328, 176-187.

49. A novel imidazopyridine PI3K inhibitor with anticancer activity in non-small cell lung cancer cells

Lee, H.; Kim, S. J.; Jung, K. H.; Son, M. K.; Yan, H. H.; Hong, S.*; Hong, S.-S.*

Oncol. Rep. 2013, 30, 863.

48. Structure-Based Design of Flavone-based Inhibitors of Wild-Type and T315I Mutant of ABL

Choe, H.; Kim, J.; Hong, S.

Bioorg. Med. Chem. Lett. 2013, 23, 4324.

47. Anti-cancer effect of HS-345, a new tropomyosin-related kinase A inhibitor, on human pancreatic cancer

Seo, J.-H.;  Jung, K. H.; Son, M. K.; Yan, H. H.; Ryu, Y.-L.; Kim, J.; Lee, J. K.; Hong, S.*; Hong, S.-S.*

Cancer Lett. 2013, 338, 271.

46. Discovery of New Benzothiazole-Based Inhibitors of Breakpoint Cluster Region-Abelson Kinase Including the T315I Mutant

Hong, S.; Kim, J.; Yun, S.-M.; Lee, H.; Park, Y.; Hong, S.-S.; Hong, S.

J. Med. Chem. 2013, 56, 3531.

45. A novel PI3K inhibitor alleviates fibrotic responses in fibroblasts derived from Peyronie's plaques

Jung, K. H.; Ryu, Y.-L.; Lee, H.-S.; Lee, H.; Son, M. K.; Yan, H. H.; Hong, S.-W.; Ryu, J.-K.; Hong, S.; Suh, J.-K.; Hong, S.-S.

Int. J. Oncol.2013, 42, 2001.